title: [Churg-Strauss syndrome--recent developments in diagnosis and treatment].
authors.affiliation: Rheumaklinik Bad Bramstedt, Abteilung für Innere Medizin, Rheumatologie und Immunologie, Bad Bramstedt. hellmich@rheuma-zentrum.de
authors.forename: B
authors.initials: B
authors.lastname: Hellmich
authors.forename: C
authors.initials: C
authors.lastname: Metzler
authors.forename: W L
authors.initials: WL
authors.lastname: Gross
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D001992:Bronchoalveolar Lavage Fluid; D015267:Churg-Strauss Syndrome / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000276:immunology; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004804:Eosinophils; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000627:therapeutic use; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015994:Incidence; D000069285:Infliximab; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011379:Prognosis; D013902:Radiography, Thoracic; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage / Q000627:therapeutic use; D000069283:Rituximab; D014057:Tomography, X-Ray Computed
chemical_list: D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D019268:Antibodies, Antineutrophil Cytoplasmic; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D018124:Receptors, Tumor Necrosis Factor; D000069283:Rituximab; D003520:Cyclophosphamide; D011239:Prednisolone; D000069285:Infliximab; D000068800:Etanercept; D008727:Methotrexate